Ischemic Mitral Regurgitation
7
2
2
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
29%
2 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (7)
Coronary Heart Disease Complicated With Ischemic Mitral Regurgitation in China
Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
Serotonin Receptor Blockers in Ischemic Mitral Regurgitation
Epicardial Mitral Touch System for Mitral Insufficiency
Stress Echo for Ischemic Mitral Valve Surgery
Effect of Significant Ischemic Mitral Regurgitation on the Outcome of ST Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention
Effect of Ranolazine on Valvular Disease in Patients With Pacemakers